Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-10
DOI
10.1038/srep25776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index—Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?
- (2014) Francesco Porpiglia et al. JOURNAL OF UROLOGY
- Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis
- (2014) Wenying Wang et al. Scientific Reports
- Resultados del uso expandido del PCA3 score en una población española con sospecha de cáncer de próstata
- (2013) J. Rubio-Briones et al. Actas Urologicas Espanolas
- Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy
- (2013) Atsushi Ochiai et al. BJU INTERNATIONAL
- Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
- (2013) Vincenzo Scattoni et al. JOURNAL OF UROLOGY
- Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
- (2013) K. Kent Chevli et al. JOURNAL OF UROLOGY
- Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml
- (2013) Matteo Ferro et al. PLoS One
- Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy
- (2012) Alessandro Sciarra et al. BJU INTERNATIONAL
- PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
- (2012) Luciana Bueno Ferreira et al. BMC CANCER
- Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
- (2012) Jens Hansen et al. EUROPEAN UROLOGY
- Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases
- (2012) E. David Crawford et al. JOURNAL OF UROLOGY
- Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients
- (2012) Roland R. Goode et al. PROSTATE
- Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy
- (2012) Sisto Perdonà et al. PROSTATE
- PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?
- (2012) Pietro Pepe et al. International Braz J Urol
- The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting
- (2011) Ahmed Adam et al. BJU INTERNATIONAL
- Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration
- (2011) Qiang Shao et al. CANCER LETTERS
- Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy
- (2011) Atsushi Ochiai et al. INTERNATIONAL JOURNAL OF UROLOGY
- Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions
- (2011) Alexandre de la Taille et al. JOURNAL OF UROLOGY
- Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
- (2011) A K Wu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
- (2010) Monique J. Roobol et al. EUROPEAN UROLOGY
- Prostate Cancer Detection in the “Grey Area” of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun’s Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3
- (2010) Sisto Perdonà et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population
- (2010) Mo Shen et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The Role of PCA3 Testing in Patients with a Raised Prostate-Specific Antigen Level After Greenlight Photoselective Vaporization of the Prostate
- (2010) James Henderson et al. JOURNAL OF ENDOUROLOGY
- PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
- (2010) Sheila M.J. Aubin et al. JOURNAL OF UROLOGY
- PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine
- (2010) Marina Rigau et al. PROSTATE
- A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer
- (2010) Da-Long Cao et al. PROSTATE
- PCA3 as a diagnostic marker for prostate cancer: A validation study on a Swedish patient population
- (2010) Martin Nyberg et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Interpretation of the Prostate Cancer Gene 3 in Reference to the Individual Clinical Background: Implications for Daily Practice
- (2010) David Schilling et al. UROLOGIA INTERNATIONALIS
- Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia
- (2010) Juan Morote et al. WORLD JOURNAL OF UROLOGY
- The combination of urine DD3PCA3mRNA and PSA mRNA as molecular markers of prostate cancer
- (2009) Ettore Mearini et al. BIOMARKERS
- Rational approach to implementation of prostate cancer antigen 3 into clinical care
- (2009) Rou Wang et al. CANCER
- A Duplex Quantitative Polymerase Chain Reaction Assay Based on Quantification of α-Methylacyl-CoA Racemase Transcripts and Prostate Cancer Antigen 3 in Urine Sediments Improved Diagnostic Accuracy for Prostate Cancer
- (2009) Bin Ouyang et al. JOURNAL OF UROLOGY
- Prostate Specific Antigen Best Practice Statement: 2009 Update
- (2009) Kirsten L. Greene et al. JOURNAL OF UROLOGY
- New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression
- (2009) Raymond A. Clarke et al. PLoS One
- Differential expression ofPCA3and its overlappingPRUNE2transcript in prostate cancer
- (2009) Maciej Salagierski et al. PROSTATE
- A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
- (2008) B. Laxman et al. CANCER RESEARCH
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
- (2008) Ina L. Deras et al. JOURNAL OF UROLOGY
- PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting
- (2008) Scott B. Shappell et al. UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started